It would be interesting to see how someone arrives at .97/sh for '11.
As we have discussed, with Teva approved the number would be ~zero or less. Without Teva approved the number should be huge - at least $2 and more like $5-6. So the estimate must be based on an approval early in '11, or income from somewhere else offsetting an '10 Teva approval. Has anyone seen the actual reports?
Market Data 
Markets 
AI
